Dashboard Tools Market News Investing Ideas Pricing
Search 100,000+ stocks...
English EN
Deutsch DE
Sign Up
Log in
Alliance Pharma PLC banner
A

Alliance Pharma PLC
XBER:DVL

Watchlist Manager
Alliance Pharma PLC
XBER:DVL
Watchlist
Price: 0.404 EUR
Market Cap: €695.2m
Write Note Create Alert Ask AI
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall St Price Targets

DVL Price Targets Summary
Alliance Pharma PLC

There are no price targets for DVL.
DVL Lowest Forecast
Not Available
DVL Average Forecast
Not Available
DVL Highest Forecast
Not Available
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
Alliance Pharma PLC Competitors:
Price Targets
I
IMRX
Immuneering Corp
233% Upside
PLRX
Pliant Therapeutics Inc
127% Upside
I
IMRX
Immuneering Corp
233% Upside
PLRX
Pliant Therapeutics Inc
127% Upside

Revenue
Forecast

10% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss
10% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Over the last 14 years, the compound annual growth rate for Revenue has been 10%. The projected CAGR for the next 3 years is 9%.

What are analyst estimates?

Operating Income
Forecast

4% / Year
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss
4% / Year
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Over the last 14 years, the compound annual growth rate for Operating Income has been 4%. The projected CAGR for the next 3 years is 16%.

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-52%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-52%
Average Miss

What are analyst estimates?

See Also

Summary
DVL intrinsic value, competitors valuation, and company profile.
DCF Valuation
DVL stock valuation using Discount Cash Flow valuation method.
Relative Valuation
DVL stock valuation using valuation multiples.
Wall St Estimates
DVL price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
DVL stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Alliance Pharma PLC listings:
LSE • GBX
APH
 F • EUR
DVL
 SWB • EUR
DVL
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is DVL's stock price target?
Not Available

DVL does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for Alliance Pharma PLC?
Projected CAGR
9%

Over the last 14 years, the compound annual growth rate for Revenue has been 10%. The projected CAGR for the next 3 years is 9%.

What is the Operating Income forecast for Alliance Pharma PLC?
Projected CAGR
16%

Over the last 14 years, the compound annual growth rate for Operating Income has been 4%. The projected CAGR for the next 3 years is 16%.

Back to Top
ALPHA SPREAD
Follow us
Join 336,300+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett